Ingredia Nutritional has debuted Pep2Dia at Vitafoods Europe 2019 an ingredient to help prevent Type 2 diabetes. The dairy bioactive is the result of extensive research and collaboration between Ingredia’s scientists and LIENSs-CNRS La Rochelle University in France. Pep2Dia has proven efficacy on glycemia after meals. Pre-clinical and clinical studies support Pep2Dia’s action to reduce postprandial glycemia with a significant effect versus a placebo. Aurore Chemineau discusses one of this year’s show highlights from the Geneva event.
Upcoming webinars

Introducing LifeChews® and the Next Generation of Plant-based Supplements
Sirio

Why ARA & DHA matter: Key lipids shaping infant development
dsm-firmenich

Where Structure Drives Beauty: From Scalp Health to Skin Radiance
Monteloeder















